101 filings
Page 2 of 6
8-K
6781eak9a 8q1soz266
22 Mar 22
Entry into a Material Definitive Agreement
5:15pm
8-K
8cflo obu
16 Feb 22
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
5:15pm
8-K
vc4esk8 jk158wd
28 Dec 21
Entry into a Material Definitive Agreement
3:36pm
8-K
ov6l 5dfn
8 Dec 21
Leader in Remote Cardiac Health Monitoring Solutions, Biotricity CEO Issues 2021 Shareholder Letter
4:34pm
8-K
gf3pbz0dem 437f7
7 Dec 21
Regulation FD Disclosure
11:35am
8-K
9nqomv97ga 4qs4w29
5 Nov 21
Biotricity Releases Fiscal 2022 Second Quarter Financial Results
4:25pm
8-K
5kn sdl09p3
13 Sep 21
Biotricity Announces Closing of Exercise of Underwriter’s Option to Purchase Additional Common Stock
4:34pm
8-K
p5j2nxjcol4gakjol
10 Sep 21
Company’s Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise
3:03pm
8-K
4xrn wmbn
31 Aug 21
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
5:26pm
8-K
zhqol oso1xtcu
17 Aug 21
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
4:16pm
8-K
4rkf n8jhdn360
8 Jul 21
Biotricity’s 2021 Fiscal Fourth Quarter Growth Trend Continues into Fiscal 2022
4:34pm
8-K
rqksevogey7q
17 Jun 21
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021
4:28pm
8-K/A
6ibbbkl3o76n
27 Apr 21
Departure of Directors or Certain Officers
4:47pm
8-K
p8dgl42lz7 5def
15 Apr 21
Biotricity to Report Record Revenue Results for Fiscal 2021
3:36pm
8-K
dml2okv96
12 Feb 21
Biotricity Reports Record Revenue; Tops $1.0 Million in Quarterly Revenue for the First Time
4:01pm
8-K
zlfdk1zllstm8m9m
22 Jan 21
Entry into a Material Definitive Agreement
3:04pm
8-K
75fbrn5ntgp
31 Dec 20
Entry into a Material Definitive Agreement
4:54pm
8-K
zpd2m
20 Nov 20
Results of Operations and Financial Condition
3:38pm
8-K
p6cf6
13 Aug 20
Other Events
4:31pm
8-K
gyb9j17x
6 Aug 20
Entry into a Material Definitive Agreement
12:52pm